NLRP3 Inflammasome Contributes to Lipopolysaccharide-induced Depressive-Like Behaviors via Indoleamine 2,3-dioxygenase Induction
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Background: Inflammation may play a significant role in the pathogenesis of depression, although the molecular target for the treatment of inflammation-mediated depressive symptoms remains to be elucidated. Recent studies have implicated the NLRP3 inflammasome in various psychiatric disorders, including depression. However, the underlying mechanism by which NLRP3 inflammasome activation mediates the progression of depressive-like behaviors remains poorly understood. Methods: We examined whether NLRP3 deficiency influenced depressive-like behaviors and cerebral inflammation following systemic administration of lipopolysaccharide in mice. To further assess the contribution of the NLRP3 inflammasome to the progression of depression, we evaluated the effects of NLRP3 signaling on levels of indoleamine 2,3-dioxygenase. Results: Nlrp3-deficient mice exhibited significant attenuation of depressive-like behaviors and cerebral caspase-1 activation in a lipopolysaccharide-induced model of depression. Treatment with the antidepressant amitriptyline failed to block NLRP3-dependent activation of caspase-1, but inhibited lipopolysaccharide-promoted production of interleukin-1β mRNA via suppressing NF-κB signaling in mouse mixed glial cultures. Interestingly, lipopolysaccharide administration produced NLRP3-dependent increases in indoleamine 2,3-dioxygenase expression and activity of mouse brain. Furthermore, inflammasome-activating stimulations, but not treatment with the inflammasome product interleukin-1β, triggered indoleamine 2,3-dioxygenase mRNA induction in mixed glial cells. Conclusions: Our data indicate that the NLRP3 inflammasome is significantly implicated in the progression of systemic inflammation-induced depression. NLRP3-dependent caspase-1 activation produced significant increases in indoleamine 2,3-dioxygenase levels, which may play a significant role in lipopolysaccharide-induced depression. Collectively, our findings suggest that indoleamine 2,3-dioxygenase is a potential downstream mediator of the NLRP3 inflammasome in inflammation-mediated depressive-like behaviors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“it has been observed that stimulating NLRP3 inflammasome assembly can induce depression-like behaviors in rodents exposed to LPS or CUMS. 156 , 157”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [156]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Research on the effect of astrocyte-specific NLRP3 knockout suggests that the astrocytic NLRP3 inflammasome exerts a significant effect on astrocytic pyroptosis via the Casp-1/GSDMD pathway in depression. 156 , 157”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [156]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395 · cited 3×
“On a mechanistic basis, cytokines produced via peripheral inflammation can cross the blood-brain barrier through diffusion or some transporters and activate afferent nerves, possibly contributing to the etiology of psychiatric disorders (Dantzer et al., 2008).”
BackgroundMethodSchroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475 · cited 1×
“An inflammasome is a cytoplasmic caspase-1-activating multiprotein complex that is composed of a sensor protein such as NLRP3, an adaptor protein apoptosis-associated speck-like protein containing a caspase-recruitment domain, and an effector protein procaspase-1 (Schroder and Tschopp, 2010).”
BackgroundA Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729 · cited 1×
“In detail, the production level of proinflammatory cytokines is frequently elevated in patients with major depression (Dowlati et al., 2010).”
BackgroundDepression: a new animal model sensitive to antidepressant treatments
PORSOLT, R. D., LE PICHON, M., & JALFRE, M. (1977) · Nature · doi:10.1038/266730a0 · Cited by 4,451 · cited 1×
“At 28 h post-injection, the forced swim test (FST) was then conducted as previously described (Porsolt et al., 1977; O’Connor et al., 2009).”
MethodThe role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942 · cited 3×
“Emerging evidence has suggested that IDO acts as a central mediator of cytokine-induced depression (O’Connor et al., 2009; Walker et al., 2014; Miller and Raison, 2016) and that systemic LPS administration induces a manifest upregulation of IDO in the hippocampal region (Andre et al., 2008; Walker…”
BackgroundInfluentialThe tail suspension test: A new method for screening antidepressants in mice
Steru, L., Chermat, R., Thierry, B., & Simon, P. (1985) · Psychopharmacology · doi:10.1007/bf00428203 · Cited by 3,534 · cited 1×
“At 24 hours post injection, body weights of mice were measured, and the tail suspension test (TST) was then performed as previously described (Steru et al., 1985; O’Connor et al., 2009).”
MethodNLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898 · cited 2×
“In addition, recent studies have also proposed that NLRP3 inflammasome activation may be implicated in neuroinflammation, neurodegenerative disorders (Heneka et al., 2013; Jang et al., 2016; Zhang et al., 2016), and neuropsychiatric disorders such as depression (Alcocer-Gomez et al., 2014).”
BackgroundBelmaker, R. H., & Agam, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra073096 · Cited by 2,166
Innate immune activation in neurodegenerative disease
Heneka, M. T., Kummer, M. P., & Latz, E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3705 · Cited by 1,437 · cited 1×
“However, deregulated inflammasome activation has been increasingly implicated in the pathogenesis of metabolic or neurodegenerative disorders (Henao-Mejia et al., 2014; Heneka et al., 2014).”
BackgroundO'Connor, J. C., Lawson, M. A., André, C., Moreau, M., Lestage, J., Castanon, N., Kelley, K. W., & Dantzer, R. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002148 · Cited by 1,278 · cited 7×
“Emerging evidence has suggested that IDO acts as a central mediator of cytokine-induced depression (O’Connor et al., 2009; Walker et al., 2014; Miller and Raison, 2016) and that systemic LPS administration induces a manifest upregulation of IDO in the hippocampal region (Andre et al.”
BackgroundMethodInfluentialThe AIM2 inflammasome is critical for innate immunity to Francisella tularensis
Fernandes-Alnemri, T., Yu, J.-W., Juliana, C., Solorzano, L., Kang, S., Wu, J., Datta, P., McCormick, M., Huang, L., McDermott, E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1859 · Cited by 732
Self-citationConverging roles of caspases in inflammasome activation, cell death and innate immunity
Man, S. M., & Kanneganti, T.-D. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.7 · Cited by 701 · cited 2×
“Inflammasome components are assembled in the cytosol of myeloid cells only upon the detection of pathogen- or danger signal-derived molecular patterns and intracellular alterations by the sensor protein (Man and Kanneganti, 2016).”
BackgroundGlucocorticoids, depression, and mood disorders: Structural remodeling in the brain
McEwen, B. S. (2005) · Metabolism · doi:10.1016/j.metabol.2005.01.008 · Cited by 687 · cited 1×
“Psychological or physical stress may also be involved in the pathophysiology of depression (McEwen, 2005).”
BackgroundInflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition
Wong, M.-L., Inserra, A., Lewis, M. D., Mastronardi, C. A., Leong, L., Choo, J., Kentish, S., Xie, P., Morrison, M., Wesselingh, S. L., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.46 · Cited by 568 · cited 1×
“Caspase-1-deficient mice also exhibit a significant reduction in stress-induced depressive-like behaviors (Wong et al., 2016).”
BackgroundNeuroinflammation and comorbidity of pain and depression
Walker, A. K., Kavelaars, A., Heijnen, C. J., & Dantzer, R. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008144 · Cited by 460 · cited 3×
“Previous studies intriguingly revealed that inflammatory contexts, including LPSadministered mice and interferon α-treated patients, promote the increase in the brain level or activity of IDO (Andre et al., 2008; Walker et al., 2014; Fischer et al., 2015).”
BackgroundA role for the NLRP3 inflammasome in metabolic diseases—did Warburg miss inflammation?
Wen, H., Ting, J. P.-Y., & O'Neill, L. A. J. (2012) · Nature Immunology · doi:10.1038/ni.2228 · Cited by 457 · cited 1×
“Accumulating evidence has demonstrated that the NLRP3 inflammasome is closely implicated in the pathogenesis of many chronic inflammatory or metabolic disorders (Wen et al., 2012; Henao-Mejia et al., 2014).”
BackgroundAlcocer-Gómez, E., de Miguel, M., Casas-Barquero, N., Núñez-Vasco, J., Sánchez-Alcazar, J. A., Fernández-Rodríguez, A., & Cordero, M. D. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.10.017 · Cited by 443 · cited 6×
“Recent evidence further suggests that the NLRP3 inflammasome is implicated in depressive disorders (Alcocer-Gomez et al., 2014; Zhang et al., 2015; Xu et al., 2016).”
BackgroundResultInfluentialWalker, A. K., Budac, D. P., Bisulco, S., Lee, A. W., Smith, R. A., Beenders, B., Kelley, K. W., & Dantzer, R. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.71 · Cited by 432 · cited 1×
“, 2014; Miller and Raison, 2016) and that systemic LPS administration induces a manifest upregulation of IDO in the hippocampal region (Andre et al., 2008; Walker et al., 2013).”
BackgroundIwata, M., Ota, K. T., Li, X.-Y., Sakaue, F., Li, N., Dutheil, S., Banasr, M., Duric, V., Yamanashi, T., Kaneko, K., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.11.026 · Cited by 387 · cited 2×
“Of interest, NLRP3 inflammasome may act as a crucial sensor for psychological stress to trigger brain inflammation (Iwata et al., 2016).”
BackgroundBlack, R. A., Kronheim, S. R., Cantrell, M., Deeley, M. C., March, C. J., Prickett, K. S., Wignall, J., Conlon, P. J., Cosman, D., & Hopp, T. P. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)76559-4 · Cited by 380 · cited 1×
“Unlike other proinflammatory cytokines, the production of active IL-1β requires unique posttranslational processing of inactive precursor pro-IL-1β by active caspase-1 (Black et al., 1988).”
BackgroundNLRP3 inflammasome-driven pathways in depression: clinical and preclinical findings
Kaufmann, F. N., Costa, A. P., Ghisleni, G., Diaz, A. P., Rodrigues, A. L. S., Peluffo, H., & Kaster, M. P. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.03.002 · Cited by 370 · cited 1×
“Major depressive disorder is a neuropsychiatric disorder associated with multiple environmental risk factors, including inflammation (Kaufmann et al., 2017).”
BackgroundNLRP3 Inflammasome Mediates Chronic Mild Stress-Induced Depression in Mice via Neuroinflammation
Zhang, Y., Liu, L., Liu, Y.-Z., Shen, X.-L., Wu, T.-Y., Zhang, T., Wang, W., Wang, Y.-X., & Jiang, C.-L. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv006 · Cited by 325 · cited 2×
“Recent evidence further suggests that the NLRP3 inflammasome is implicated in depressive disorders (Alcocer-Gomez et al., 2014; Zhang et al., 2015; Xu et al., 2016).”
BackgroundXu, Y., Sheng, H., Bao, Q., Wang, Y., Lu, J., & Ni, X. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.02.022 · Cited by 298 · cited 2×
“Recent evidence further suggests that the NLRP3 inflammasome is implicated in depressive disorders (Alcocer-Gomez et al., 2014; Zhang et al., 2015; Xu et al., 2016).”
BackgroundPsychiatric Symptoms in Patients With Chronic Hepatitis C Receiving Interferon Alfa-2b Therapy
Kraus, M. R., Schafer, A., Faller, H., Csef, H., & Scheurlen, M. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0614 · Cited by 245 · cited 1×
“Additionally, patients undergoing type 1 interferon therapy showed a higher risk for psychiatric symptoms such as depression (Kraus et al., 2003), indicating that peripheral inflammation is frequently associated with depressive disorder.”
BackgroundAlcocer-Gómez, E., Casas-Barquero, N., Williams, M. R., Romero-Guillena, S. L., Cañadas-Lozano, D., Bullón, P., Sánchez-Alcazar, J. A., Navarro-Pando, J. M., & Cordero, M. D. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.04.028 · Cited by 215 · cited 7×
“Recent evidence further suggests that the NLRP3 inflammasome is implicated in depressive disorders (Alcocer-Gomez et al., 2014; Zhang et al., 2015; Xu et al., 2016).”
BackgroundResultInfluentialCazareth, J., Guyon, A., Heurteaux, C., Chabry, J., & Petit-Paitel, A. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-132 · Cited by 206 · cited 2×
“Cells were then analyzed via flow cytometry, and CD45+CD11b+ cells were considered as CNSassociated phagocytes (Cazareth et al., 2014).”
BackgroundMethodClinical and Physiological Consequences of Rapid Tryptophan Depletion
Moore, P. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00161-5 · Cited by 205 · cited 1×
“IDO catabolizes tryptophan (Trp) into kynurenine (Kyn), which lead to attenuation of neurotransmitter serotonin production (Moore et al., 2000; Walker et al., 2014).”
BackgroundMitochondria and the NLRP3 inflammasome: physiological and pathological relevance
Yu, J.-W., & Lee, M.-S. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0827-4 · Cited by 205 · cited 3×
“Given that diverse stress signals including microbial toxins, particulate matters, and osmotic stress can stimulate the NLRP3 inflammasome (Yu and Lee, 2016), it is highly likely that psychological stress, a major cause of depression, activates NLRP3-dependent inflammasome signaling (Iwata et al.,…”
BackgroundSelf-citationInvolvement of inflammasome activation in lipopolysaccharide-induced mice depressive-like behaviors
Zhang, Y., Liu, L., Peng, Y., Liu, Y., Wu, T., Shen, X., Zhou, J., Sun, D., Huang, A., Wang, X., et al. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12170 · Cited by 200 · cited 1×
“Furthermore, selective inhibition of caspase-1 by VX-765 or YVAD significantly attenuates depressive-like behaviors triggered by diverse stimulations such as lipopolysaccharide (LPS) injection, chronic mild stress, and estrogen deficiency (Zhang et al., 2014, 2015; Xu et al., 2016).”
BackgroundInflammasomes and Metabolic Disease
Henao‐Mejia, J., Elinav, E., Thaiss, C. A., & Flavell, R. A. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021113-170324 · Cited by 179 · cited 2×
“Accumulating evidence has demonstrated that the NLRP3 inflammasome is closely implicated in the pathogenesis of many chronic inflammatory or metabolic disorders (Wen et al., 2012; Henao-Mejia et al., 2014).”
BackgroundStress-Induced Depressive Behaviors Require a Functional NLRP3 Inflammasome
Alcocer-Gómez, E., Ulecia-Morón, C., Marín-Aguilar, F., Rybkina, T., Casas-Barquero, N., Ruiz-Cabello, J., Ryffel, B., Apetoh, L., Ghiringhelli, F., Bullón, P., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9408-7 · Cited by 172 · cited 3×
“Moreover, stress-induced depressive phenotypes were markedly attenuated in Nlrp3-deficient mice (Alcocer-Gomez et al., 2016), indicating that NLRP3-mediated inflammasome signaling plays a significant role in the progression of depressive-like behaviors.”
BackgroundResultJang, J., Park, S., Jin Hur, H., Cho, H.-J., Hwang, I., Pyo Kang, Y., Im, I., Lee, H., Lee, E., Yang, W., et al. (2016) · Nature Communications · doi:10.1038/ncomms13129 · Cited by 166 · cited 1×
“In addition, recent studies have also proposed that NLRP3 inflammasome activation may be implicated in neuroinflammation, neurodegenerative disorders (Heneka et al., 2013; Jang et al., 2016; Zhang et al., 2016), and neuropsychiatric disorders such as depression (Alcocer-Gomez et al., 2014).”
BackgroundSelf-citationInflammation Models of Depression in Rodents: Relevance to Psychotropic Drug Discovery
Remus, J. L., & Dantzer, R. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw028 · Cited by 164 · cited 3×
“To minimize the overlap with sickness response, we performed behavioral tests after 24 hours of LPS injection similar to experimental designs from previous reports (Dantzer et al., 2008; Remus and Dantzer, 2016).”
MethodLawson, M. A., Parrott, J. M., McCusker, R. H., Dantzer, R., Kelley, K. W., & O’Connor, J. C. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-87 · Cited by 161 · cited 1×
“Moreover, selective inhibition of IDO1 by 1-methyl-tryptophan significantly attenuates depressive-like behaviors in mice treated with LPS (O’Connor et al., 2009; Lawson et al., 2013b).”
MethodZhu, W., Cao, F.-S., Feng, J., Chen, H.-W., Wan, J.-R., Lu, Q., & Wang, J. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2016.11.037 · Cited by 134 · cited 1×
“Previous studies showed that LPS administration to mice causes acute or long-term depression-like behaviors as well as acute sickness behaviors (O’Connor et al., 2009; Lawson et al., 2013a; Zhu et al., 2017).”
BackgroundAndré, C., O’Connor, J. C., Kelley, K. W., Lestage, J., Dantzer, R., & Castanon, N. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.06.011 · Cited by 118 · cited 3×
“Given that IDO may be a potent mediator between inflammation and depression (Andre et al., 2008; O’Connor et al., 2009; Miller and Raison, 2016), we assessed levels of Ido mRNA expression in the mouse brain.”
BackgroundObuchowicz, E., Kowalski, J., Labuzek, K., Krysiak, R., Pendzich, J., & Herman, Z. S. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570500547x · Cited by 115 · cited 2×
“Another study further demonstrated that amitriptyline suppresses the release of IL-1β in LPS-stimulated rat mixed glial cells (Obuchowicz et al., 2006).”
BackgroundHutchinson, M. R., Loram, L. C., Zhang, Y., Shridhar, M., Rezvani, N., Berkelhammer, D. L., Phipps, S., Foster, P. S., Landgraf, K., Falke, J. J., et al. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.03.067 · Cited by 110 · cited 1×
“Our data are consistent with the previous study showing that amitriptyline inhibits toll-like receptor 4 signaling (Hutchinson et al., 2010).”
ResultC dk5‐ D ependent A ctivation of N euronal I nflammasomes in P arkinson's D isease
Zhang, P., Shao, X., Qi, G., Chen, Q., Bu, L.-L., Chen, L., Shi, J., Ming, J., & Tian, B. (2016) · Movement Disorders · doi:10.1002/mds.26488 · Cited by 105 · cited 1×
“In addition, recent studies have also proposed that NLRP3 inflammasome activation may be implicated in neuroinflammation, neurodegenerative disorders (Heneka et al., 2013; Jang et al., 2016; Zhang et al., 2016), and neuropsychiatric disorders such as depression (Alcocer-Gomez et al., 2014).”
BackgroundRole of brain transmigrating neutrophils in depression-like behavior during systemic infection
Aguliar-Valles, A., Kim, J., Jung, S., Woodside, B., & Luheshi, G. N. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.137 · Cited by 97
Lawson, M. A., McCusker, R. H., & Kelley, K. W. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-54 · Cited by 80 · cited 1×
“Moreover, selective inhibition of IDO1 by 1-methyl-tryptophan significantly attenuates depressive-like behaviors in mice treated with LPS (O’Connor et al., 2009; Lawson et al., 2013b).”
MethodFischer, C. W., Eskelund, A., Budac, D. P., Tillmann, S., Liebenberg, N., Elfving, B., & Wegener, G. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.07.015 · Cited by 62 · cited 1×
“Previous studies intriguingly revealed that inflammatory contexts, including LPSadministered mice and interferon α-treated patients, promote the increase in the brain level or activity of IDO (Andre et al., 2008; Walker et al., 2014; Fischer et al., 2015).”
BackgroundKim, E., Won, J.-H., Hwang, I., & Yu, J. (2013) · Immune Network · doi:10.4110/in.2013.13.4.141 · Cited by 22 · cited 1×
“Mouse brain mixed glial cells were prepared from the whole brains of mouse pups on the first postnatal day as previously described (Kim et al., 2013) and cultured in DMEM/F-12 medium supplemented with 10% FBS and 100 U/mL penicillin/streptomycin for 2 to 3 weeks.”
MethodSelf-citation
Cited by
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Cui, L., Li, S., Wang, S., Wu, X., Liu, Y., Yu, W., Wang, Y., Tang, Y., Xia, M., & Li, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01738-y · Cited by 1,244
“156,157 Research on the effect of astrocyte-speci fi c NLRP3 knockout suggests that the astrocytic NLRP3 in fl ammasome exerts a signi fi cant effect on astrocytic pyroptosis via the Casp-1/GSDMD pathway in depression.”
BackgroundArioz, B. I., Tastan, B., Tarakcioglu, E., Tufekci, K. U., Olcum, M., Ersoy, N., Bagriyanik, A., Genc, K., & Genc, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01511 · Cited by 516
“Behavioral and molecular evidences of DLB being inhibited by NLRP3 inhibitor support that inflammasome activation plays role in the disease pathogenesis (19).”
BackgroundLi, S., Sun, Y., Song, M., Song, Y., Fang, Y., Zhang, Q., Li, X., Song, N., Ding, J., Lu, M., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.146852 · Cited by 321
“tion or chronic unpredictable mild stress (CUMS) stimulation (50, 51).”
BackgroundDepression's Unholy Trinity: Dysregulated Stress, Immunity, and the Microbiome
Cruz-Pereira, J. S., Rea, K., Nolan, Y. M., O'Leary, O. F., Dinan, T. G., & Cryan, J. F. (2020) · Annual Review of Psychology · doi:10.1146/annurev-psych-122216-011613 · Cited by 320
“In a fascinating study, cerebral cavernous malformations—vascular defects that potentiate the risk of seizure and hemorrhagic stroke—were found to be stimulated by activation of endothelial Toll-like receptor 4 (TLR4), which is involved in the activation of innate immunity, by gram-negative bacteria and LPS (Tang et a…”
BackgroundInfluentialKouba, B. R., de Araujo Borba, L., Borges de Souza, P., Gil-Mohapel, J., & Rodrigues, A. L. S. (2024) · Cells · doi:10.3390/cells13050423 · Cited by 209
“However, in a different study, amitriptyline (20 or 50 µ M for 1 h) was unable to mitigate caspase-1 activation after stimulation of mouse glial cells with LPS/ATP or LPS/nigericin [234].”
Background
Metadata
- Authors
- Jeon, S.-A., Lee, E., Hwang, I., Han, B., Park, S., Son, S., Yang, J., Hong, S., Kim, C. H., Son, J., & Yu, J.-W.
- Affiliations
- Yonsei University (KR)
- Corresponding author
- Yu, Je-Wook
- Venue
- International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-07-31
- Volume
- 20
- Issue
- 11
- Pages
- 896-906
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- PMC
- PMC5737528
- OpenAlex
- W2741260697
- Cited by
- 62
- References
- 44
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 12 · 2023: 4 · 2022: 6 · 2021: 6 · 2020: 8 · 2019: 11 · 2018: 2
- FWCI
- 1.91
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- The International Journal of Neuropsychopharmacology (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
- Funders
- National Research Foundation of Korea (2014R1A4A1008625, 2017R1A2B2007467)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- NLRP3 inflammasome, depression, lipopolysaccharide, indoleamine 2,3-dioxygenase, caspase-1, IL-1β, NF-κB signaling, systemic inflammation, depression-like behavior, amitriptyline, neuroinflammation
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Amitriptyline, Analysis of Variance, Animals, Brain, Cells, Cultured, Depression, Disease Models, Animal, Dose-Response Relationship, Drug, Enzyme Activation, Lipopolysaccharides, Mice, Inbred C57BL, Neuroglia, RNA, Messenger, Gene Expression Regulation, Enzymologic, Cytokines, Mice, Knockout, Caspase 1, Indoleamine-Pyrrole 2,3,-Dioxygenase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.